Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

STDs

- PMLiVE

A new option for people with HIV

ViiV Healthcare's dolutegravir could capture a significant share of the HIV market and may have blockbuster potential

- PMLiVE

Mylan to sell Gilead’s medicines in India

Includes HIV treatments Viread, Truvada and Stribild

- PMLiVE

ViiV wins European approval for Tivicay

HIV treatment licensed in combination with other anti-retroviral drugs

- PMLiVE

Genetic Digital launches new app offering

Genetic Apps will develop tools for HCPs, patients and sports enthusiasts

Google testing smart contact lens for people with diabetes

Prototype devices use miniaturised electronics to measure glucose levels

- PMLiVE

Europe approaches mHealth tipping point

Drop the industry shorthand and a significant proportion of consumers are now open to mobile health tools

UK faces ‘mountain high’ barriers to mHealth adoption

Doesn't help that industry shorthand is little understood by consumers

- PMLiVE

FDA clears Isentress formulation for infants with HIV

Merck's integrase inhibitor available for children as young as four weeks

2013: pharma’s year of mobile?

Industry use of the technology stepped up a gear this year

Merck turns to gamification in diabetes

Working with Ayogo on mobile app to improve adherence

WebMD to debut quantified self venture in 2014

Will launch mobile biometric tracking via new iPhone app plus ecommerce store for devices

Mobile app formulary and cloud hosting platform launched

IMS Health stakes its claim in mHealth

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links